Skip to main content
SpringerLink
Log in
Book cover

Sleep in Children with Neurodevelopmental Disabilities pp 253–261Cite as

Fragile X Syndrome

  • Chapter
  • First Online:

  • 1040 Accesses

Abstract

This chapter offers a synopsis of research studies identifying various sleep patterns in children with Fragile X syndrome. New research has begun to recognize sleep problems across the life span in individuals with Fragile X-associated disorders. Epidemiologic and treatment approaches involve recognizing the interaction of biopsychosocial variables which have been conceptualized using the International Classification of Functioning, Disability and Health-Children and Youth Version. There is a need for well-designed double-blind crossover studies investigating the effectiveness of medications and behavioral interventions in treating sleep problems. The immediate and long-term impact of these treatments on family satisfaction and functioning must also be measured and documented.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Chonchaiya W, Schneider A, Hagerman RJ. Fragile X: a family of disorders. Adv Pediatr. 2009;56(1):165–86.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Hessl D, Rivera SM, Reiss AL. The neuroanatomy and neuroendocrinology of fragile X syndrome. Ment Retard Dev Disabil Res Rev. 2004;10(1):17–24.

    Article  PubMed  Google Scholar 

  3. Coffee B, Keith K, Albizua I, Malone T, Mowrey J, Sherman SL, Warren ST. Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNA. Am J Hum Genet. 2009;85(4):503–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Bailey DB, Raspa M, Olmsted M, Holiday DB. Co-occurring conditions associated with FMR1 gene variations: findings from a national parent survey. Am J Med Genet A. 2008;146(16):2060–9.

    Article  CAS  Google Scholar 

  5. Monaghan KG, Lyon E, Spector EB. ACMG Standards and Guidelines for fragile X testing: a revision to the disease-specific supplements to the standards and guidelines for clinical genetics Laboratories of the American College of medical genetics and genomics. Genet Med. 2013;15(7):575–86.

    Article  CAS  PubMed  Google Scholar 

  6. Dombrowski C, Levesque S, Morel M, Rouillard P, Morgan K, Rousseau F. Premutation and intermediate-size FMR1 alleles in 10 572 males from the general population: loss of an AGG interruption is a late event in the generation of fragile X syndrome alleles. Hum Mol Genet. 2002;11(4):371–8.

    Article  CAS  PubMed  Google Scholar 

  7. Pesso R, Berkenstadt M, Cuckle H, Gak E, Peleg L, Frydman M, Barkai G. Screening for fragile X syndrome in women of reproductive age. Prenat Diagn. 2000;20(8):611–4.

    Article  CAS  PubMed  Google Scholar 

  8. Rousseau F, Rouillard P, Morel M-L, Khandjian EW, Morgan K. Prevalence of carriers of premutation-size alleles of the FMRI gene--and implications for the population genetics of the fragile X syndrome. Am J Hum Genet. 1995;57(5):1006.

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Tzeng CC, Tsai LP, Hwu WL, Lin SJ, et al. Prevalence of the FMR1 mutation in Taiwan assessed by large-scale screening of newborn boys and analysis of DXS548-FRAXAC1 haplotype. Am J Med Genet A. 2005;133(1):37–43.

    Article  Google Scholar 

  10. Fernandez-Carvajal I, Posadas BL, Pan R, Raske C, Hagerman PJ, Tassone F. Expansion of an FMR1 grey-zone allele to a full mutation in two generations. J Mol Diagn. 2009;11(4):306–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Jacquemont S, Hagerman RJ, Leehey MA, Hall DA, et al. Penetrance of the fragile X–associated tremor/ataxia syndrome in a premutation carrier population. JAMA. 2004;291(4):460–9.

    Article  CAS  PubMed  Google Scholar 

  12. Coffey SM, Cook K, Tartaglia N, Tassone F, et al. Expanded clinical phenotype of women with the FMR1 premutation. Am J Med Genet A. 2008;146(8):1009–16.

    Article  Google Scholar 

  13. Hagerman RJ, Hall DA, Coffey S, Leehey M, et al. Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems. Clin Interv Aging. 2008;3(2):251.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Jacquemont S, Hagerman RJ, Leehey M, Grigsby J, et al. Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates. Am J Hum Genet. 2003;72(4):869–78.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Hamlin A, Liu Y, Nguyen DV, Tassone F, Zhang L, Hagerman RJ. Sleep apnea in fragile X premutation carriers with and without FXTAS. Am J Med Genet B Neuropsychiatr Genet. 2011;156(8):923–8.

    Article  CAS  Google Scholar 

  16. Summers S, Cogswell J, Goodrich J, Mu Y, Nguyen D, Brass S, Hagerman R. Prevalence of restless legs syndrome and sleep quality in carriers of the fragile X premutation. Clin Genet. 2014;86(2):181–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Sullivan SD, Welt C, Sherman S. FMR1 and the continuum of primary ovarian insufficiency. Semin Reprod Med. 2011; 29(4):299–307.

    Article  PubMed  Google Scholar 

  18. Cronister A, Teicher J, Rohlfs EM, Donnenfeld A, Hallam S. Prevalence and instability of fragile X alleles: implications for offering fragile X prenatal diagnosis. Obstet Gynecol. 2008;111(3):596–601.

    Article  CAS  PubMed  Google Scholar 

  19. Seltzer MM, Baker MW, Hong J, Maenner M, Greenberg J, Mandel D. Prevalence of CGG expansions of the FMR1 gene in a US population-based sample. Am J Med Genet B Neuropsychiatr Genet. 2012;159(5):589–97.

    Article  CAS  PubMed Central  Google Scholar 

  20. Tassone F, Iong KP, Tong T-H, Lo J, et al. FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States. Genome Med. 2012;4(12):100.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Nolin SL, Sah S, Glicksman A, Sherman SL, et al. Fragile X AGG analysis provides new risk predictions for 45–69 repeat alleles. Am J Med Genet A. 2013;161(4):771–8.

    Article  CAS  Google Scholar 

  22. Yrigollen CM, Durbin-Johnson B, Gane L, Nelson DL, Hagerman R, Hagerman PJ, Tassone F. AGG interruptions within the maternal FMR1 gene reduce the risk of offspring with fragile X syndrome. Genet Med. 2012;14(8):729–36.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Hall DA, Berry-Kravis E, Zhang W, Tassone F, et al. FMR1 gray-zone alleles: association with Parkinson’s disease in women? Mov Disord. 2011;26(10):1900–6.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Loesch D, Tassone F, Lo J, Slater H, et al. New evidence for, and challenges in, linking small CGG repeat expansion FMR1 alleles with Parkinson’s disease. Clin Genet. 2013;84(4):382–5.

    Article  CAS  PubMed  Google Scholar 

  25. Hall D, Tassone F, Klepitskaya O, Leehey M. Fragile X–associated tremor ataxia syndrome in FMR1 gray zone allele carriers. Mov Disord. 2012;27(2):297–301.

    Article  CAS  Google Scholar 

  26. Liu Y, Winarni T, Zhang L, Tassone F, Hagerman R. Fragile X-associated tremor/ataxia syndrome (FXTAS) in grey zone carriers. Clin Genet. 2013;84(1):74–7.

    Article  CAS  PubMed  Google Scholar 

  27. Bretherick KL, Fluker MR, Robinson WP. FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure. Hum Genet. 2005;117(4):376–82.

    Article  CAS  PubMed  Google Scholar 

  28. Renda MM, Voigt RG, Babovic-Vuksanovic D, Highsmith WE, Vinson SS, Sadowski CM, Hagerman RJ. Neurodevelopmental disabilities in children with intermediate and premutation range fragile X cytosine-guanine-guanine expansions. J Child Neurol. 2014;29(3):326–30.

    Article  PubMed  Google Scholar 

  29. Bechara EG, Didiot MC, Melko M, Davidovic L, et al. A novel function for fragile X mental retardation protein in translational activation. PLoS Biol. 2009;7(1):133.

    Article  CAS  Google Scholar 

  30. Bushey D, Tononi G, Cirelli C. The Drosophila fragile X mental retardation gene regulates sleep need. J Neurosci. 2009;29(7):1948–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Bushey D, Tononi G, Cirelli C. Sleep and synaptic homeostasis: structural evidence in Drosophila. Science. 2011;332(6037):1576–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. van Alphen B, Yap MH, Kirszenblat L, Kottler B, van Swinderen B. A dynamic deep sleep stage in Drosophila. J Neurosci. 2013;33(16):6917–27.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  33. Tirosh E, Borochowitz Z. Sleep apnea in fragile X syndrome. Am J Med Genet. 1992;43(1–2):124–7.

    Article  CAS  PubMed  Google Scholar 

  34. Ferri R, Del Gracco S, Elia M, Musumeci SA, Pettinato S. Heart rate variability and autonomic function during sleep in fragile X syndrome. Am J Med Genet. 1999;83(4):296–7.

    Article  CAS  PubMed  Google Scholar 

  35. Gould EL, Loesch DZ, Martin MJ, Hagerman RJ, Armstrong SM, Huggins RM. Melatonin profiles and sleep characteristics in boys with fragile X syndrome: a preliminary study. Am J Med Genet. 2000;95(4):307–15.

    Article  CAS  PubMed  Google Scholar 

  36. Miano S, Bruni O, Elia M, Scifo L, et al. Sleep phenotypes of intellectual disability: a polysomnographic evaluation in subjects with Down syndrome and fragile-X syndrome. Clin Neurophysiol. 2008;119(6):1242–7.

    Article  PubMed  Google Scholar 

  37. Wirojanan J, Jacquemont S, Diaz R, Bacalman S, Anders TF, Hagerman RJ, Goodlin-Jones BL. The efficacy of melatonin for sleep problems in children with autism, fragile X syndrome, or autism and fragile X syndrome. J Clin Sleep Med. 2009;5(2):145.

    PubMed  PubMed Central  Google Scholar 

  38. Kronk R, Dahl R, Noll R. Caregiver reports of sleep problems on a convenience sample of children with fragile X syndrome. Am J Intellect Dev Disabil. 2009;114(6):383–92.

    Article  PubMed  Google Scholar 

  39. Kronk R, Bishop EE, Raspa M, Bickel JO, Mandel DA, Bailey DB Jr. Prevalence, nature, and correlates of sleep problems among children with fragile X syndrome based on a large scale parent survey. Sleep. 2010;33(5):679.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Symons FJ, Byiers BJ, Raspa M, Bishop E, Bailey DB Jr. Self-injurious behavior and fragile X syndrome: findings from the national fragile X survey. Am J Intellect Dev Disabil. 2010;115(6):473–81.

    Article  PubMed  Google Scholar 

  41. Chervin RD, Archbold KH, Panahi P, Pituch KJ. Sleep problems seldom addressed at two general pediatric clinics. Pediatrics. 2001;107(6):1375–80.

    Article  CAS  PubMed  Google Scholar 

  42. Mindell JA, Owens JA. Sleep problems in pediatric practice: clinical issues for the pediatric nurse practitioner. J Pediatr Health Care. 2003;17(6):324–31.

    PubMed  Google Scholar 

  43. Owens JA. The practice of pediatric sleep medicine: results of a community survey. Pediatrics. 2001;108(3):e51.

    Article  CAS  PubMed  Google Scholar 

  44. Lewandowski AS, Toliver-Sokol M, Palermo TM. Evidence-based review of subjective pediatric sleep measures. J Pediatr Psychol. 2011;36(7):780–93.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Kidd SA, Lachiewicz A, Barbouth D, Blitz RK, et al. Fragile X syndrome: a review of associated medical problems. Pediatrics. 2014;134(5):995–1005.

    Article  PubMed  Google Scholar 

  46. Owens JA, Spirito A, McGuinn M. The Children’s Sleep Habits Questionnaire (CSHQ): psychometric properties of a survey instrument for school-aged children. Sleep. 2000;15(23):1043–51.

    Google Scholar 

  47. Goldman SE, Richdale AL, Clemons T, Malow BA. Parental sleep concerns in autism spectrum disorders: variations from childhood to adolescence. J Autism Dev Disord. 2012;42(4):531–8.

    Article  PubMed  Google Scholar 

  48. Souders MC, Mason TB, Valladares O, Bucan M, et al. Sleep behaviors and sleep quality in children with autism spectrum disorders. Sleep. 2009;32(12):1566.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Gruber R, Fontil L, Bergmame L, Wiebe ST, Amsel R, Frenette S, Carrier J. Contributions of circadian tendencies and behavioral problems to sleep onset problems of children with ADHD. BMC Psychiatry. 2012;12(1):212.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Sciberras E, Fulton M, Efron D, Oberklaid F, Hiscock H. Managing sleep problems in school aged children with ADHD: a pilot randomised controlled trial. Sleep Med. 2011;12(9):932–5.

    Article  PubMed  Google Scholar 

  51. Lara Ledesma D. A Spanish version of the Children’s Sleep Habits Questionnaire (CSHQ). Electronic Theses, Projects, and Dissertations 2014;Paper 89. http://scholarworks.lib.csusb.edu/etd/89.

  52. Liu X, Liu L, Owens JA, Kaplan DL. Sleep patterns and sleep problems among schoolchildren in the United States and China. Pediatrics. 2005;115(Suppl 1):241–9.

    Article  PubMed  Google Scholar 

  53. Tzchishinsky O, Lufi D, Shochat T. Reliability of the Children’s Sleep Habits Questionnaire Hebrew translation and cross cultural comparison of the psychometric properties. Sleep Diagn Ther. 2008;3:30–4.

    Google Scholar 

  54. Sadeh A. Commentary: comparing actigraphy and parental report as measures of children’s sleep. J Pediatr Psychol. 2008;33(4):406–7.

    Article  PubMed  Google Scholar 

  55. World Health Organization. International classification of functioning, disability, and health: children & youth version: ICF-CY. World Health Organization; 2007.

    Google Scholar 

  56. Mindell JA, Owens JA. A clinical guide to pediatric sleep: diagnosis and management of sleep problems. Philadelphia, PA: Lippincott Williams & Wilkins; 2015.

    Google Scholar 

  57. Weiskop S, Richdale A, Matthews J. Behavioural treatment to reduce sleep problems in children with autism or fragile X syndrome. Dev Med Child Neurol. 2005;47(02):94–104.

    Article  PubMed  Google Scholar 

  58. Kulman G, Lissoni P, Rovelli F, Roselli MG, Brivio F, Sequeri P. Evidence of pineal endocrine hypofunction in autistic children. Neuroendocrinol Lett. 2000;21(1):31–4.

    PubMed  Google Scholar 

  59. Tordjman S, Anderson GM, Pichard N, Charbuy H, Touitou Y. Nocturnal excretion of 6-sulphatoxymelatonin in children and adolescents with autistic disorder. Biol Psychiatry. 2005;57(2):134–8.

    Article  CAS  PubMed  Google Scholar 

  60. Tordjman S, Anderson GM, Bellissant E, Botbol M, et al. Day and nighttime excretion of 6-sulphatoxymelatonin in adolescents and young adults with autistic disorder. Psychoneuroendocrinology. 2012;37(12):1990–7.

    Article  CAS  PubMed  Google Scholar 

  61. Bailey DB, Raspa M, Bishop E, Olmstead M, Mallya U, Berry-Kravis E. Medication utilization for targeted symptoms in children and adults with fragile X syndrome: US survey. J Dev Behav Pediatr. 2012;33:62–9.

    Article  PubMed  Google Scholar 

  62. Angriman M, Caravale B, Novelli L, Ferri R, Bruni O. Sleep in children with neurodevelopmental disabilities. Neuropediatrics. 2015;46(3):199–210.

    Article  PubMed  Google Scholar 

  63. Hollway JA, Aman MG. Pharmacological treatment of sleep disturbance in developmental disabilities: a review of the literature. Res Dev Disabil. 2011;32(3):939–62.

    Article  PubMed  Google Scholar 

  64. Appleton R, Jones AP, Gamble C, Williamson PR, et al. The use of melatonin in children with neurodevelopmental disorders and impaired sleep: a randomized, double-blind, placebo-controlled, parallel study (MENDS). Health Technol Assess. 2012;16(40):8–239.

    Article  Google Scholar 

  65. Hagerman R, Riddle J, Roberts L, Breese K, Fulton M. Survey of the efficacy of clonidine in fragile X syndrome. Dev Brain Dysfunct. 1995;8(4–6):336–44.

    Google Scholar 

  66. Ming X, Gordon E, Kang N, Wagner GC. Use of clonidine in children with autism spectrum disorders. Brain Dev. 2008;30(7):454–60.

    Article  PubMed  Google Scholar 

  67. Raspa M, Bailey DB Jr, Bishop E, Holiday D, Olmsted M. Obesity, food selectivity, and physical activity in individuals with fragile X syndrome. Am J Intellect Dev Disabil. 2010;115(6):482–95.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nursing, Duquesne University, Pittsburgh, PA, USA

    Rebecca Kronk

  2. Fragile X Clinic, Movement Disorders Clinic, Tourette Syndrome Clinic, Division of Child Neurology, Children’s Hospital of Pittsburgh, Pittsburgh, PA, USA

    Robyn A. Filipink

Authors
  1. Rebecca Kronk
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robyn A. Filipink
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rebecca Kronk .

Editor information

Editors and Affiliations

  1. Departments of Pediatrics and Neurology, Virginia Commonwealth University School of Medicine, Richmond, VA, USA

    Jennifer A. Accardo

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kronk, R., Filipink, R.A. (2019). Fragile X Syndrome. In: Accardo, J. (eds) Sleep in Children with Neurodevelopmental Disabilities. Springer, Cham. https://doi.org/10.1007/978-3-319-98414-8_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-98414-8_22

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-98412-4

  • Online ISBN: 978-3-319-98414-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation